triflusal has been researched along with Blood Clot in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García, E; Guarinos, J; Ioannidis, K; Larman, M; Moreu, J; Ortas, MR; Piqué, N; Puigfel, B; Rincón, A; Rumoroso, JR; Serra, A; Zueco, JJ | 1 |
| Arumugam, S; Boey, FY; Huang, Y; Mohanty, M; Umashankar, PR; Venkatraman, SS | 1 |
| Arumugam, S; Boey, FY; Huang, Y; Khanolkar, L; Lahti, EM; Mohanty, M; Umashankar, PR; Vaishnav, S; Venkatraman, SS | 1 |
| Badimon, L; Duran, X; Sánchez, S; Vilahur, G | 1 |
| Forn, J; García Rafanell, J; Ramis, J; Sánchez, MS | 2 |
| Aranza Perea, J; Arcas, R; Herreros, J; Honorato, J; Rocha, E | 1 |
| Garcia Rafanell, J; Planas, JM; Puig-Parellada, P | 1 |
| Bellés, L; Forn, J; García Rafanell, J | 1 |
| Alvarez, L; Castillo-Olivares, JL; de Haro, J; Escudero, MC; Millán, I; Rodríguez, V | 1 |
| Alvarez, L; Castillo-Olivares, JL; del Moral, JH; Escudero-Vela, MC; Millán, I; Rodríguez, V | 1 |
1 trial(s) available for triflusal and Blood Clot
| Article | Year |
|---|---|
Long-term clinical performance of paclitaxel-eluting stents coated with a bioactive polymer (P-5) containing a triflusal derivative: results of the REWAC registry.
Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Polymers; Prospective Studies; Registries; Salicylates; Thrombosis; Treatment Outcome | 2013 |
10 other study(ies) available for triflusal and Blood Clot
| Article | Year |
|---|---|
The short-term effect on restenosis and thrombosis of a cobalt-chromium stent eluting two drugs in a porcine coronary artery model.
Topics: Animals; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Chromium Alloys; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Therapy, Combination; Drug-Eluting Stents; Immunosuppressive Agents; Platelet Aggregation Inhibitors; Prosthesis Design; Salicylates; Sirolimus; Swine; Thrombosis; Treatment Outcome | 2009 |
In vitro and in vivo performance of a dual drug-eluting stent (DDES).
Topics: Animals; Antibiotics, Antineoplastic; Coated Materials, Biocompatible; Drug Delivery Systems; Drug-Eluting Stents; Humans; Hyperplasia; Materials Testing; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Salicylates; Sirolimus; Surface Properties; Swine; Thrombosis | 2010 |
Protective effects of triflusal on secondary thrombus growth and vascular cyclooxygenase-2.
Topics: Animals; Aspirin; Base Sequence; Blood Vessels; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; DNA Primers; Endothelium, Vascular; Fibrinolytic Agents; In Vitro Techniques; Male; Perfusion; Rabbits; Recurrence; RNA, Messenger; Salicylates; Thrombosis | 2008 |
[Effect of chronic administration of triflusal on pulmonary thrombosis induced by arachidonic acid].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Female; Fibrinolytic Agents; Male; Rats; Rats, Inbred Strains; Salicylates; Thrombosis | 1982 |
[Induction of pulmonary thrombosis in the rat by i.v. injections of ADP and the antithrombotic activity of triflusal].
Topics: Adenosine Diphosphate; Animals; Female; Fibrinolytic Agents; Injections, Intravenous; Lung Diseases; Male; Rats; Rats, Inbred Strains; Salicylates; Thrombosis | 1982 |
[Clinico-biological effectiveness of triflusal during the postoperative period of patients with chronic ischemic syndrome of the extremities].
Topics: Adult; Aged; Blood Vessel Prosthesis; Drug Evaluation; Endarterectomy; Female; Fibrinolytic Agents; Humans; Ischemia; Leg; Male; Middle Aged; Postoperative Complications; Salicylates; Thrombosis | 1981 |
Comparison of the inhibitory effects of acetylsalicylic acid and trifusal on enzymes related to thrombosis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Aspirin; Cattle; Cyclooxygenase Inhibitors; Fibrinolytic Agents; Horses; In Vitro Techniques; Microsomes; Myocardial Contraction; Oxidoreductases; Salicylates; Sheep; Thrombosis; Thromboxane-A Synthase | 1979 |
[Induction of pulmonary thrombosis in mice, rabbits and hamsters by intravenous injection of arachidonic acid. Comparative study of 3 experimental models in vivo and the antithrombotic activity of triflusal].
Topics: Animals; Arachidonic Acids; Cricetinae; Disease Models, Animal; Fibrinolytic Agents; Injections, Intravenous; Lung Diseases; Mice; Rabbits; Respiration Disorders; Salicylates; Thrombosis | 1979 |
[Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs].
Topics: Animals; Aspirin; Dipyridamole; Dogs; Drug Evaluation; Drug Therapy, Combination; Platelet Aggregation Inhibitors; Salicylates; Thrombosis | 1989 |
Prevention of the formation of arterial thrombi using different antiplatelet drugs: experimental study in dogs.
Topics: Animals; Aspirin; Dipyridamole; Dogs; Indium Radioisotopes; Platelet Aggregation Inhibitors; Salicylates; Scintillation Counting; Thrombosis | 1989 |